Action Quest PharmaTech - QPT

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

0,03

Prix Achat

0,025

Prix Vente

0,03

Volume échangé

30 007

0,03 Fourchette du Jour 0,03

0,00 Plage de 52 semaines 0,00

Cap du marché

5,074M

Clôture Veille

0,02

Ouverture

0,03

Dernière Transaction

10000

0.03

Dernière heure de transaction

16:35:46

Volume financier

VWAP

Volume moyen (3 m)

Actions en circulation

169 129 000

Rendement du Dividende

Ratio Cours sur Bénéfices

-1,69

Bénéfice par action (BPA)

-0,02

Chiffre d'affairess

Bénéfice net

-3,02M

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.questpharmatech.com

Siège social

Edmonton, Alberta, Can

Fondé

Quest PharmaTech Inc est coté dans le secteur Pharmaceutical Preparations de la TSX Venture Exchange avec le ticker QPT. Le dernier cours de clôture d'Quest PharmaTech était de $0,02. Au cours de la dernière année, les actions de Quest PharmaTech ont été négociées dans une fourchette de prix de $ 0,00 à $ 0,00.

Quest PharmaTech compte actuellement 169 129 000 actions en circulation. La capitalisation boursière d'Quest PharmaTech est de $3,38 million. Quest PharmaTech a un ratio cours/bénéfice (ratio PE) de -1.69.

Quest PharmaTech Announces Results from AGM

EDMONTON, Alberta, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the...

Quest PharmaTech Receives U.S. $2 Million for its Immuno-Photodynamic Therapy Assets

Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”), a pharmaceutical company developing and commercializing products to improve...

Quest PharmaTech to Market and Distribute Premium Anti-Wrinkle Skin Care Product, Bellus Skin™; Dr. Jacqueline Shan, Creato...

Quest PharmaTech to Market and Distribute Premium Anti-Wrinkle Skin Care Product, Bellus Skin™; Dr. Jacqueline Shan, Creator of COLD...

Quest PharmaTech Completes Patient Enrollment in Phase IIb Study of Oregovomab for the Immunotherapy of Ovarian Cancer

Quest PharmaTech Completes Patient Enrollment in Phase IIb Study of Oregovomab for the Immunotherapy of Ovarian Cancer PR Newswire EDMONTON, June...

Quest PharmaTech strengthens its Antibody Immunotherapy Technology by licensing anti-MUC1 IgE Technology from Stanford Univer...

Quest PharmaTech strengthens its Antibody Immunotherapy Technology by licensing anti-MUC1 IgE Technology from Stanford University; Researchers to...

Quest PharmaTech Establishes Joint Venture with Korean-Based AD Biotech Co., Ltd. to Develop Immunotherapeutic Products for C...

Quest PharmaTech Establishes Joint Venture with Korean-Based AD Biotech Co., Ltd. to Develop Immunotherapeutic Products for Cancer PR...

Quest PharmaTech Signs Exclusive License Agreement with UCLA for anti - PSA IgE Technology; UCLA researchers to present anti ...

Quest PharmaTech Signs Exclusive License Agreement with UCLA for anti - PSA IgE Technology; UCLA researchers to present anti - PSA IgE...

Quest PharmaTech Enrolls 40th Patient in its Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial for Ovarian Ca...

Quest PharmaTech Enrolls 40th Patient in its Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial for Ovarian Cancer in Italy and...

Quest PharmaTech Acquires Immunoglobulin E Technology to Strengthen its Combination Therapy Approach for the Treatment of Can...

Quest PharmaTech Acquires Immunoglobulin E Technology to Strengthen its Combination Therapy Approach for the Treatment of Cancer PR...

Quest PharmaTech Updates Progress of Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial in Italy

Quest PharmaTech Updates Progress of Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial in Italy PR Newswire EDMONTON, July 10...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

QPT - Frequently Asked Questions (FAQ)

What is the current Quest PharmaTech share price?

The current share price of Quest PharmaTech is $ 0,03

How many Quest PharmaTech shares are in issue?

Quest PharmaTech has 169 129 000 shares in issue

What is the market cap of Quest PharmaTech?

The market capitalisation of Quest PharmaTech is CAD 3,38M

What is the 1 year trading range for Quest PharmaTech share price?

Quest PharmaTech has traded in the range of $ 0,00 to $ 0,00 during the past year

What is the PE ratio of Quest PharmaTech?

The price to earnings ratio of Quest PharmaTech is -1,69

What is the reporting currency for Quest PharmaTech?

Quest PharmaTech reports financial results in CAD

What is the latest annual profit for Quest PharmaTech?

The latest annual profit of Quest PharmaTech is CAD -3,02M

What is the registered address of Quest PharmaTech?

The registered address for Quest PharmaTech is 4342 - 97 STREET NW,EDMONTON, EDMONTON, ALBERTA, T6E 5R9

What is the Quest PharmaTech website address?

The website address for Quest PharmaTech is www.questpharmatech.com

Which industry sector does Quest PharmaTech operate in?

Quest PharmaTech operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
KLXCarbon Done Right Developments Inc	$ 0,015 (50,00%)	2k
QPTQuest PharmaTech Inc	$ 0,03 (50,00%)	30,01k
MSPMinaean SP Construction Corp	$ 0,015 (50,00%)	194k
HBKHighbank Resources Ltd	$ 0,015 (50,00%)	1 000
DEALPlaygon Games Inc	$ 0,015 (50,00%)	15,5k
MTKMontauk Metals Inc	$ 0,005 (-50,00%)	1 000
KUR.HKure Technologies Inc	$ 0,03 (-50,00%)	1 000
HCC.HHanna Capital Corp	$ 0,005 (-50,00%)	5k
GLIGlacier Lake Resources Inc	$ 0,04 (-42,86%)	455k
LONELithium One Metals Inc	$ 0,01 (-33,33%)	10k
BCMBear Creek Mining Corporation	$ 0,225 (-25,00%)	2,37M
QNCQuantum Emotion Corp	$ 0,62 (0,00%)	1,83M
EMOEmerita Resources Corp	$ 1,31 (-5,07%)	1,64M
OMGOmai Gold Mines Corp	$ 0,355 (-1,39%)	1,44M
AIRClean Air Metals Inc	$ 0,05 (0,00%)	1,41M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Quest PharmaTech Inc (QPT)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Quest PharmaTech Inc

QPT Dernières nouvelles

Quest PharmaTech Announces Results from AGM

Quest PharmaTech Receives U.S. $2 Million for its Immuno-Photodynamic Therapy Assets

Quest PharmaTech to Market and Distribute Premium Anti-Wrinkle Skin Care Product, Bellus Skin™; Dr. Jacqueline Shan, Creato...

Quest PharmaTech Completes Patient Enrollment in Phase IIb Study of Oregovomab for the Immunotherapy of Ovarian Cancer

Quest PharmaTech strengthens its Antibody Immunotherapy Technology by licensing anti-MUC1 IgE Technology from Stanford Univer...

Quest PharmaTech Establishes Joint Venture with Korean-Based AD Biotech Co., Ltd. to Develop Immunotherapeutic Products for C...

Quest PharmaTech Signs Exclusive License Agreement with UCLA for anti - PSA IgE Technology; UCLA researchers to present anti ...

Quest PharmaTech Enrolls 40th Patient in its Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial for Ovarian Ca...

Quest PharmaTech Acquires Immunoglobulin E Technology to Strengthen its Combination Therapy Approach for the Treatment of Can...

Quest PharmaTech Updates Progress of Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial in Italy

Quest PharmaTech Announces Results from AGM

QPT - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Quest PharmaTech Inc (QPT) Cours

Quest PharmaTech Inc (QPT)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Quest PharmaTech Inc

QPT Dernières nouvelles

Quest PharmaTech Announces Results from AGM

Quest PharmaTech Receives U.S. $2 Million for its Immuno-Photodynamic Therapy Assets

Quest PharmaTech to Market and Distribute Premium Anti-Wrinkle Skin Care Product, Bellus Skin™; Dr. Jacqueline Shan, Creato...

Quest PharmaTech Completes Patient Enrollment in Phase IIb Study of Oregovomab for the Immunotherapy of Ovarian Cancer

Quest PharmaTech strengthens its Antibody Immunotherapy Technology by licensing anti-MUC1 IgE Technology from Stanford Univer...

Quest PharmaTech Establishes Joint Venture with Korean-Based AD Biotech Co., Ltd. to Develop Immunotherapeutic Products for C...

Quest PharmaTech Signs Exclusive License Agreement with UCLA for anti - PSA IgE Technology; UCLA researchers to present anti ...

Quest PharmaTech Enrolls 40th Patient in its Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial for Ovarian Ca...

Quest PharmaTech Acquires Immunoglobulin E Technology to Strengthen its Combination Therapy Approach for the Treatment of Can...

Quest PharmaTech Updates Progress of Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial in Italy

Quest PharmaTech Announces Results from AGM

QPT - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS